This overlooked hormone could be why your blood pressure won’t drop
A large U.S. study reveals that more than a quarter of people with hard-to-treat high blood pressure may have an overlooked hormone problem. Elevated cortisol—often linked to stress—was found in 27% of these patients, far higher than expected. This...
schedule
07:50 visibility
109 views
Source: Science Daily
A large U.S. study reveals that more than a quarter of people with hard-to-treat high blood pressure may have an overlooked hormone problem. Elevated cortisol—often linked to stress—was found in 27% of these patients, far higher than expected. This hidden condition could explain why standard medications fail. The discovery could lead to new testing and treatments that finally help bring blood pressure under control.
François Picard is pleased to welcome Bilal Saab, Senior Managing Director of the Trends Research Group and a close friend of Lebanese President Joseph Aoun. Mr. Saab offers a cautiously optimistic assessment of a pivotal moment in Lebanese...
Tomorrow's foldable-centric Galaxy Unpacked event looks like it will be Samsung's biggest in years. The company is expected to launch new versions of its Fold and Flip phones while also introducing a brand new Fold form factor that's shorter and...
Nintendo does a lot of weird things, but Splatoon might just be one of the strangest - or at least the boldest. The series started as an attempt to muscle into the ultra-competitive online shooter space, but in a way that feels a world away from the...
AI-generated animal footage is racking up millions of views online, but researchers warn it is also distorting public understanding of wildlife behaviour and could be undermining support for conservation.
Elif C., İstanbul’da tanıştığı bir kişinin kliniğinde saçlarına yaptırdığı ‘somon dna’ işlemi yüzünden adeta kabusu yaşadı. Şüpheli Şeyma Y., tarafından uygulanan enjeksiyon işleminden sonra Elif C.’nin...Devamı için tıklayınız
AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.
TechCrunch
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more